|Year : 2016 | Volume
| Issue : 2 | Page : 107-111
Effect of myomectomy on endometrial cavity: A prospective study of 51 cases
Shilpa Bhandari, Ishita Ganguly, Pallavi Agarwal, Aparna Singh, Nitika Gupta
Department of Reproductive Medicine and Surgery, Sri Aurobindo Medical College and Post Graduate Institute, Indore, Madhya Pradesh, India
|Date of Submission||28-Sep-2015|
|Date of Decision||28-Dec-2015|
|Date of Acceptance||12-Apr-2016|
|Date of Web Publication||6-Jun-2016|
Department of Reproductive Medicine and Surgery, Sri Aurobindo Medical College and Post Graduate Institute, Indore - 453 010, Madhya Pradesh
Source of Support: None, Conflict of Interest: None
| Abstract|| |
CONTEXT: Fibroids are the most common tumors of the uterine cavity. Most of them are diagnosed during the reproductive age when the fertility is an important concern for the female. However, complications can occur after removal of fibroid (myomectomy) too for future pregnancy. Though myomectomy has been sighted as a cause of intrauterine adhesions data regarding the effect of myomectomy on endometrial cavity is lacking. AIMS: Evaluate the incidence of intrauterine adhesion formation after myomectomy and to identify the associated factors. MATERIALS AND METHODS: In this prospective observational study, hysteroscopy was done in 51 infertile patients who had undergone myomectomy 3 months before in a tertiary care center from 2012 to 2015. The presence of intrauterine adhesions noted on hysteroscopy was investigated on the basis of size, number, location and type of fibroid removed, along with intraoperative breach of the uterine cavity. STATISTICAL ANALYSIS: Chi-square test was used for the calculating significant difference in frequency of discrete variables in two groups. P < 0.05 was considered significant. RESULTS: Intrauterine adhesions were seen in 11 out of 51 (21.57%) cases. No significant relationship between intrauterine adhesions and type, size or number of fibroid was observed. No statistical difference in the rate of adhesion formation was seen irrespective of breach of the uterine cavity during myomectomy. CONCLUSION: Intrauterine adhesion formation after myomectomy is not related to the type of surgery or the nature of fibroid. However, in all cases desiring fertility postoperative hysteroscopy is highly recommended to diagnose and treat these adhesions early.
Keywords: Endometrial lining, intrauterine adhesions, myomectomy
|How to cite this article:|
Bhandari S, Ganguly I, Agarwal P, Singh A, Gupta N. Effect of myomectomy on endometrial cavity: A prospective study of 51 cases. J Hum Reprod Sci 2016;9:107-11
|How to cite this URL:|
Bhandari S, Ganguly I, Agarwal P, Singh A, Gupta N. Effect of myomectomy on endometrial cavity: A prospective study of 51 cases. J Hum Reprod Sci [serial online] 2016 [cited 2023 Mar 27];9:107-11. Available from: https://www.jhrsonline.org/text.asp?2016/9/2/107/183509
| Introduction|| |
Uterine fibroids are the most common benign tumors of the uterus. Fibroids are considered to be solely responsible for impaired fertility in 2–3% of cases of infertility., Minimally invasive myomectomy by hysteroscopy or laparoscopy, as opposed to hysterectomy, is the prefered surgical procedure for patients who wish to preserve fertility. The advantages of the laparoscopic approach against laparotomy are well established. Although the efficacy of myomectomy per se on restoring fertility has never been proven by a randomized clinical trial, fibroids are held responsible for infertility in various studies. The size, number, and location of these fibroids affect women's fertility as a result of distortion of the endometrial cavity, which causes abnormal endometrial receptivity and hormonal milieu. The effect of fibroid on endometrial receptivity has been the subject of numerous studies. The exact mechanism by which fibroids affect endometrial receptivity and the role of myomectomy, if any in improving it is still a matter of debate. It is however beyond doubt that myomectomy in itself being a major invasive procedure runs the risk of damage to uterine myometrium as well as endometrium.
Intrauterine trauma, especially to the basal layer of endometrium is responsible for intrauterine adhesions. Very few previous studies, have mentioned the possible role of myomectomy in causing intrauterine adhesions. In the preservation of uterus for the purpose of future fertility, it is essential to also understand the impact of myomectomy on endometrium and thereby on implantation.
The purpose of the present study is to evaluate the frequency of uterine adhesions following myomectomy and the impact of number, size, and location of fibroid and intraoperative breach of the endometrial cavity on the same.
| Materials and Methods|| |
This prospective study was conducted in the Department of Reproductive Medicine and Surgery, of a tertiary care center from 2012 to 2015. Infertile patients requiring myomectomy prior to in vitro fertilization (IVF) were considered for the study. Patients were excluded from the cohort in the presence of any of the following (1) presence of any other uterine anomaly (2) history of previous uterine surgery. (3) The presence of intrauterine adhesions prior to myomectomy.
The preoperative patient profile including ultrasonography findings and details of type of fibroids, size, location, and number were recorded. Sonography was performed by a single experienced operator (Pallavi Agarwal) on IU-22 (Phillips) with a transvaginal probe 5 Hz or a transabdominal probe 3-5 Hz. Fibroids were classified according to the International Federation of Gynecology and Obstetrics classification system and the location as described on the transvaginal scan. Patients with a hybrid of fibroid types (i.e., both intramural [IM] and subserosal [SS] fibroids) were placed into the IM category, and patients with both submucous (SM) and other fibroids were placed into the SM category. The single largest diameter of fibroid was measured to note size.
Myomectomy was done by a single operator (Shilpa Bhandari). The laparoscopic approach was used in cases of IM and subserous fibroids, while hysteroscopic myomectomy was done in submucous fibroids. Hysteroscopy was performed intraoperatively in order to determine the type of myoma and detect the intrauterine pathology, if any. Concerning closure of myoma bed two-layer closure was done with vicryl 1/0 (polyglactin 9467; Ethicon, Neuilly, France). When uterine cavity was opened, the defect was closed separately. Injecting methylene blue transcervically identified uterine defect. Patients were given a high dose of oral contraceptive pills in dose of ethinyl estradiol (50 mg), to prevent spontaneous conception for a period of 1–3 months.
Three months after myomectomy, all patients were subjected to diagnostic hysteroscopy in their postmenstrual phase. Findings of hysteroscopy, especially presence of any adhesions were noted and graded as mild, moderate, and severe based on extend and type of adhesions found on hysteroscopy and according to following [Table 1].
Eventually, the occurrence rate and severity of intrauterine adhesions and its relationship with type (SS, IM, and submucous), size, and number of myoma and also the opening condition of endometrium were investigated. Statistical analysis was done using Chi-square test. A P < 0.05 was considered significant.
No specific approval for this study was required from the Institutional Ethical Committee as the technique used was standard surgical procedure and hysteroscopy is routinely performed for all patients undergoing IVF at our center. However, detailed consent was taken from all patients for operative procedures.
| Results|| |
A total of 51 patients were considered in the study. The mean age of participants was 32.76 ± 5.26 years. Most of the participants (37, 72.55%) were cases of primary infertility. Of the 14 patients of secondary subfertility, 5 had previous live births while 2 had more than 3 abortions, and rest had 1–3 abortions. The patient profile is summarized in [Table 2]. Thirty-one (60.78%) were solitary fibroids and 78.43% were IM. The average single largest diameter was 7.58 cm.
Of the 51 patients who underwent myomectomy, intrauterine adhesions were observed in the consequent hysteroscopy in 11 cases (21.57%). Of these 11 adhesion cases, mild adhesions were noted in seven cases, while moderate adhesions were present in three cases. Severe type of adhesion was observed in only one patient.
When the type of fibroid (IM, submucous, or subserous) was considered, we observed that in cases of submucous fibroids (undergoing hysteroscopic myomectomy) postoperative intrauterine adhesions were seen in 40% of cases. No significant association of type of fibroid with postoperative intrauterine adhesion was observed [Table 3].
In the present case series [Table 3], seven patient had fibroids >10 cm. The incidence of intrauterine adhesion formation is highest (28.57%) in this group when compared to cases where fibroid was <10 cm. The percentage of intrauterine adhesions was also higher than the average in cases with fibroid >10 cm. However, the difference in the rate of adhesion formation in different groups based on single largest diameter does not reach statistical significance.
Patients with submucous fibroid were not considered when an intraoperative breach of the endometrial cavity was considered to investigate the presence of postoperative intrauterine adhesions. We also did not observed any association of degree of severity of adhesion with the cavity breach [Table 3].
Majority of the fibroids in our series were solitary. The incidence of intrauterine adhesions was highest in cases with more than five fibroids removed during the surgery (50%). However, no significant difference in the incidence of adhesion was observed in groups according to numbers of fibroids present [Table 3].
[Table 3] shows hysteroscopy findings according to SM and IM group. No significant difference was observed in terms of degree of adhesion, location of fibroids, size of fibroids, and presence of cavity breech in two groups [Table 4].
|Table 4: Hysteroscopic findings according to submucous and intramural group|
Click here to view
| Discussion|| |
Myomectomy causes trauma due to visceral peritoneal incision, opening of myometrium, removal of fibroid, and closure of muscle margin by suture. This tissue trauma leads to classical inflammatory reaction and either a regenerative response or a fibrotic response for tissue healing. The over all risk of myomectomy is low, but the heterogeneity of fibroid and the variability in surgical procedure makes it difficult to study the association between myomectomies and risk of adhesions.
Numerous studies have studied the incidence of peritoneal adhesions after myomectomy but very few which have evaluated intrauterine adhesions after myomectomy., Indeed, reasonable evidence exists on the risk of development of adhesions following uterine surgery such as cesarean section or myomectomy.,, In a large observational study of 91 patients, Fauconnier et al. found a cumulative probability of conception after myomectomy to be lower when uterine sutures were required. They postulated adhesions to be responsible for lowered fertility. It is possible that apart from peritoneal adhesions, intrauterine adhesions may also occur, secondary to ischemia of myoma bed or direct endometrial injury.
The incidence of intrauterine adhesions was 21.57% in our series which is similar to that reported by Asgari et al. In a prospective study, uterine adhesions were diagnosed in 2 out of 32 (6.25%) patients by hysterosalpingography after myomectomy. This study did not consider confirmation of postoperative findings with hysteroscopy nor did it take into consideration any variables pertaining to fibroid. In a prospective study of 36 women undergoing open myomectomy incidence of intrauterine adhesions was found to be 50%. The authors concluded that open myomectomy in itself represents an important cause of intrauterine adhesions.
Hysteroscopic myomectomy is an important risk factor for intrauterine adhesions. In a prospective study by Taskin et al., a second-look diagnostic hysteroscopy showed mild intrauterine adhesions in the 37.5% of patients after monopolar resection of a single fibroid and in the 45% after resection of multiple fibroids. This incidence is similar to our own (2/5, 40%). In many other studies, the rate of intrauterine adhesions is variable from 1.07% to 78%,, depending on the use of electrocautry and adhesion preventive strategies. In our studies, though the sample size is very small, we have not found a difference in the incidence of intrauterine adhesions in cases operated for submucous mommas and IM/subserous types. Larger randomized trials are required to further evaluate the relationship between the type of fibroid and intrauterine adhesions.
Damage to endometrium is considered to be a significant factor in the causation of intrauterine adhesions. However, we have found that formation of intrauterine adhesions is not statistically associated with the opening of endometrium intraoperative. In a retrospective analysis, Gupta et al. found a 30% incidence of intrauterine adhesions in cases of abdominal myomectomy where the uterine cavity was breached. However, the cases where intrauterine adhesions were diagnosed were historical controls that had undergone myomectomy in past and wherein uterine cavity was opened. The authors have not elaborated on the technique of closure nor have eliminated bias due to prolonged interval between myomectomy and hysteroscopy. Gambadauro et al. in 2012 also found a significantly higher occurrence of synechiae when the endometrium was opened. In cases where the endometrium was not opened the possibility of necrosis and fibrosis secondary to tissue ischemia can be responsible for the formation of intrauterine adhesions. Intrauterine adhesions have been reported in cases undergoing uterine artery embolization for fibroid too. These findings demonstrate that surgical trauma is not essential for the development of synechiae.
We have not found a significant association between the size of fibroid and incidence of postoperative intrauterine adhesions. In a study similar to ours, Asgari et al. have found a significant relation between the two. However, this difference was found to be significant only in the severe type of intrauterine adhesions. The size of fibroid may be related to the degree of myometrial defect and consequent scar formation. Larger sample size is required to clearly correlate fibroid size and incidence of intrauterine adhesions. Conforti et al. in a small prospective study too did not find a significant association between size and number of fibroid with adhesion formation.
Asgari et al. found a positive correlation between number of fibroids and intrauterine adhesions in their studies. In our series, though the incidence of adhesions was higher than average in large fibroids (>10 cm), the relation was not statistically significant. In one of the largest series of myomectomy, complications rates were significantly associated with the size of fibroid. However, the major complications mentioned in this series are intraoperative and postoperative surgical complications. Intrauterine adhesions are not specifically mentioned.
We have not used any adhesion barriers such as hyaluronic acid-carboxymethylcellulose film (Seprafilm®), dextran 40 (10% dextran 40 Low Injection®), factor 13 with fibrinogen (Beriplast®), or various pharmacological agents such as high dose of estrogen and progesterone, gonadotropin-releasing hormone agonist as adhesion preventive agents in our study to reduce financial burden on the patients, and to find out true incidence of postoperative adhesions in the absence of use of any adhesion barriers.
Long-term follow-up with larger sample size is required to understand the true impact of myomectomy on intrauterine adhesions and consequently on implantation, pregnancy, and live birth rates.
| Conclusion|| |
Myomectomy is a commonly performed surgery in women of reproductive age group desiring fertility. Myomectomy in itself represents a possible cause for intrauterine adhesions irrespective of nature, type, and location of fibroid and whether or not the uterine cavity was opened during surgery. Therefore, in patients planning for pregnancy, hysteroscopy should be done postoperatively to diagnose and rule out intrauterine adhesion.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Lethaby AE Vollenhoven BJ. Fibroids (uterine myomatosis, leiomyomas). Clin Evid (Online) 2009;05:814-38.
Practice Committee of the American Society for Reproductive Medicine. Myomas and reproductive function. Fertil Steril 2006;86 5 Suppl 1:S194-9.
Dubuisson JB, Fauconnier A, Deffarges JV, Norgaard C, Kreiker G, Chapron C. Pregnancy outcome and deliveries following laparoscopic myomectomy. Hum Reprod 2000;15:869-73.
Segars JH, Parrott EC, Nagel JD, Guo XC, Gao X, Birnbaum LS, et al.
Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: Comprehensive review, conference summary and future recommendations. Hum Reprod Update 2014;20:309-33.
Rackow BW, Taylor HS. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril 2010;93:2027-34.
Sinclair DC, Mastroyannis A, Taylor HS. Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-ß3. J Clin Endocrinol Metab 2011;96:412-21.
Gambadauro P, Gudmundsson J, Torrejón R. Intrauterine adhesions following conservative treatment of uterine fibroids. Obstet Gynecol Int 2012;2012:853269.
Asgari Z, Hafizi L, Hosseini R, Javaheri A, Rastad H. Intrauterine synechiae after myomectomy; laparotomy versus laparoscopy: Non-randomized interventional trial. Iran J Reprod Med 2015;13:161-8.
March CM, Israel R, March AD. Hysteroscopic management of intrauterine adhesions. Am J Obstet Gynecol 1978;130:653-7.
Ahmad G, Duffy JM, Farquhar C, Vail A, Vandekerckhove P, Watson A, et al.
Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2008;(2):CD000475.
Papoutsis D, Georgantzis D, Daccó MD, Halmos G, Moustafa M, Mesquita Pinto AR, et al.
A rare case of Asherman's syndrome after open myomectomy: Sonographic investigations and possible underlying mechanisms. Gynecol Obstet Invest 2014;77:194-200.
Lev-Toaff AS, Karasick S, Toaff ME. Hysterosalpingography before and after myomectomy: Clinical value and imaging findings. AJR Am J Roentgenol 1993;160:803-7.
Nakhuda GS, Douglas NC, Sauer MV. Clinically significant uterine synechiae caused by transmural uterine incisions. J Gynecol Surg 2005;21:95-8.
Fauconnier A, Dubuisson JB, Ancel PY, Chapron C. Prognostic factors of reproductive outcome after myomectomy in infertile patients. Hum Reprod 2000;15:1751-7.
Taskin O, Sadik S, Onoglu A, Gokdeniz R, Erturan E, Burak F, et al.
Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery. J Am Assoc Gynecol Laparosc 2000;7:351-4.
Yang JH, Chen MJ, Wu MY, Chao KH, Ho HN, Yang YS. Office hysteroscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas. Fertil Steril 2008;89:1254-9.
Gupta S, Talaulikar VS, Onwude J, Manyonda I. A pilot study of Foley's catheter balloon for prevention of intrauterine adhesions following breach of uterine cavity in complex myoma surgery. Arch Gynecol Obstet 2013;288:829-32.
Mara M, Fucikova Z, Kuzel D, Maskova J, Dundr P, Zizka Z. Hysteroscopy after uterine fibroid embolization in women of fertile age. J Obstet Gynaecol Res 2007;33:316-24.
Conforti A, Krishnamurthy GB, Dragamestianos C, Kouvelas S, Micallef Fava A, Tsimpanakos I, et al.
Intrauterine adhesions after open myomectomy: An audit. Eur J Obstet Gynecol Reprod Biol 2014;179:42-5.
Sizzi O, Rossetti A, Malzoni M, Minelli L, La Grotta F, Soranna L, et al.
Italian multicenter study on complications of laparoscopic myomectomy. J Minim Invasive Gynecol 2007;14:453-62.
Tsuji S, Takahashi K, Yomo H, Fujiwara M, Kita N, Takebayashi K, et al.
Effectiveness of antiadhesion barriers in preventing adhesion after myomectomy in patients with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 2005;123:244-8.
Imai A, Sugiyama M, Furui T, Takahashi S, Tamaya T. Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy. J Obstet Gynaecol 2003;23:660-3.
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||Prevention strategies of postoperative adhesion in soft tissues by applying biomaterials: Based on the mechanisms of occurrence and development of adhesions
| ||Jie Liao, Xiaoming Li, Yubo Fan |
| ||Bioactive Materials. 2023; 26: 387 |
|[Pubmed] | [DOI]|
||Incidence and risk factors of intrauterine adhesions after myomectomy
| ||Pietro Bortoletto, Kimberly W. Keefe, Emily Unger, Eduardo Hariton, Antonio R. Gargiulo |
| ||F&S Reports. 2022; |
|[Pubmed] | [DOI]|
||Fibroids and Fertility: A Comparison of Myomectomy and Uterine Artery Embolization on Fertility and Reproductive Outcomes
| ||Nicole C. Zanolli, Katherine C. Bishop, Jeffrey A. Kuller, Thomas M. Price, Benjamin S. Harris |
| ||Obstetrical & Gynecological Survey. 2022; 77(8): 485 |
|[Pubmed] | [DOI]|
||Prevalence of Intrauterine Adhesions after Myomectomy: A Prospective Multicenter Observational Study
| ||Antonio Simone Laganà, Simone Garzon, Susan Dababou, Stefano Uccella, Mykhailo Medvediev, Darya Pokrovenko, Evgenia Leonidovna Babunashvili, Svetlana Nikolaevna Buyanova, Natalya Alekseevna Schukina, Marina Gennadievna Shcherbatykh Kaschchuk, Ioannis Kosmas, Martina Licchelli, Gaetano Panese, Andrea Tinelli |
| ||Gynecologic and Obstetric Investigation. 2022; 87(1): 62 |
|[Pubmed] | [DOI]|
||Comparison of ultrasound-guided high-intensity focused ultrasound ablation and hysteroscopic myomectomy for submucosal fibroids: a retrospective study
| ||Waixing Li, Zhipeng Yang, Bingsi Gao, Lingxiao Zou, Dabao Xu, Lu Liu, Pan Gu, Xinliang Deng |
| ||International Journal of Hyperthermia. 2021; 38(1): 1609 |
|[Pubmed] | [DOI]|
||Hysteroscopic findings after laparoscopic and open myomectomy with or without uterine cavity breach: historical cohort study
| ||Barbora Boudova, Kristyna Hlinecka, Zdenka Lisa, Adela Richtarova, Zdenek Zizka, Michal Mara |
| ||Minimally Invasive Therapy & Allied Technologies. 2021; : 1 |
|[Pubmed] | [DOI]|
||Patient-reported menstrual and obstetric outcomes following hysteroscopic adhesiolysis for Asherman syndrome
| ||Blanca Morales, Peter Movilla, Joyce Wang, Jennifer Wang, Alexandria Williams, Tammy Chen, Himabindu Reddy, Jovana Tavcar, Megan Loring, Stephanie Morris, Keith Isaacson |
| ||F&S Reports. 2021; 2(1): 118 |
|[Pubmed] | [DOI]|
||Mini-Review of the New Therapeutic Possibilities in Asherman Syndrome—Where Are We after One Hundred and Twenty-Six Years?
| ||Bogdan Doroftei, Ana-Maria Dabuleanu, Ovidiu-Dumitru Ilie, Radu Maftei, Emil Anton, Gabriela Simionescu, Theodor Matei, Theodora Armeanu |
| ||Diagnostics. 2020; 10(9): 706 |
|[Pubmed] | [DOI]|
||Preliminary design of a new degradable medical device to prevent the formation and recurrence of intrauterine adhesions
| ||Salome Leprince, Stéphanie Huberlant, Lucie Allegre, Sophie Warembourg, Isabelle Leteuff, Audrey Bethry, Cedric Paniagua, Hubert Taillades, Renaud De Tayrac, Jean Coudane, Vincent Letouzey, Xavier Garric |
| ||Communications Biology. 2019; 2(1) |
|[Pubmed] | [DOI]|